Safety and efficacy of sunitinib in patients with unresectable pancreatic neuroendocrine tumors. (Record no. 22333232)

MARC details
000 -LEADER
fixed length control field 00770 a2200205 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516124243.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201212s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1179-5549
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.4137/CMO.S7350
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Wiedmann, Marcus W
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20121211
245 00 - TITLE STATEMENT
Title Safety and efficacy of sunitinib in patients with unresectable pancreatic neuroendocrine tumors.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Clinical Medicine Insights. Oncology
Date of publication, distribution, etc. 2012
300 ## - PHYSICAL DESCRIPTION
Extent 381-93 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mössner, Joachim
773 0# - HOST ITEM ENTRY
Title Clinical Medicine Insights. Oncology
Related parts vol. 6
-- p. 381-93
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.4137/CMO.S7350">https://doi.org/10.4137/CMO.S7350</a>
Public note Available from publisher's website

No items available.